Drug

D0781 | apigenin

Molecular Formula C15H10O5
Molecular Weight 270.24
Structure
State solid

Toxicity Dose Time Species Model Method Action Positive criterion Reference
MEMBRANE POTENTIAL 1.61±0.00 human qHTS-HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 3.55 human HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 28.93±9.26 rat hepatocytes MMP assay decrease IC50 163
ELECTRON TRANSPORT CHAIN 105 μM  rat brain MF0F1-ATPase decrease IC50 140

Target Dose Time Species Model Method Action Positive criterion Reference
ATP synthase 105 μM  rat brain MF0F1-ATPase inhibitor IC50 140

Pictogram Signal Statements Precautionary Statement Codes

Aggregated GHS information provided by 29 companies from 2 notifications to the ECHA C&L Inventory.


Reported as not meeting GHS hazard criteria by 25 of 29 companies. For more detailed information, please visit ECHA C&L website


Of the 1 notification(s) provided by 4 of 29 companies with hazard statement code(s):


H412 (100%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]


Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.


P273, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)
Warning

Aggregated GHS information provided by 77 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.


Reported as not meeting GHS hazard criteria by 25 of 77 companies. For more detailed information, please visit ECHA C&L website


Of the 6 notification(s) provided by 52 of 77 companies with hazard statement code(s):


H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]


H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]


H335 (98.08%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure


Respiratory tract irritation]


Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.


P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)
Warning

Aggregated GHS information provided by 231 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.


H315 (28.57%): Causes skin irritation [Warning Skin corrosion/irritation]


H412 (71.43%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]


Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.


P264, P273, P280, P302+P352, P321, P332+P313, P362, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)

Organism Test type Route Dose (normalized dose) Effect Source
rat LCLo inhalation 24000ppm/4H (24000ppm) National Technical Information Service. Vol. OTS0556683,
rat LD50 oral 3200mg/kg (3200mg/kg) National Technical Information Service. Vol. OTS0556683,
rabbit LD50 skin > 5gm/kg (5000mg/kg) Food and Cosmetics Toxicology. Vol. 12, Pg. 851, 1974.
rat LD50 oral 10gm/kg (10000mg/kg) Arzneimittel-Forschung. Drug Research. Vol. 19, Pg. 615, 1969.


  • 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone 20A365 3cf9
    4 inverted exclamation mark ,5,7-trihydroxyflavone 4 inverted exclamation marka,5,7-Trihydroxyflavone 4′,5,7-Trihydroxyflavone
    4',5,7-Trihydroxyflavone 4',5,7-Trihydroxyflavone 4',5,7-Trihydroxyflavone, 97%
    4',5,7-trihydroxy-Flavone 4',7-Trihydroxyflavone 4,5, 7-Trihydroxyflavone
    4CN-0925 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (9CI);
    4H-1-Benzopyran-4-one,7-dihydroxy-2-(4-hydroxyphenyl)- 4der 4dgm
    4hkk 5,7,4'-Trihydroxyflavone 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone
    5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one #
    5,7-dihydroxy-2-(4-hydroxyphenyl)-chromen-4-one 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one 5-18-04-00574 (Beilstein Handbook Reference)
    520-36-5 7V515PI7F6 8002-66-2
    A 3145 AB0010536 AB1011450
    AC-8011 ACN-034762 ACN-S003241
    ACon1_002450 AK-88794 AKOS002140699
    AX8015784 Apigenin Apigenin, 13
    Apigenin, >=95.0% (HPLC) Apigenin, >=97% (TLC), from citrus Apigenin, >=97% (TLC), from parsley, powder
    Apigenin, United States Pharmacopeia (USP) Reference Standard Apigenin, analytical standard Apigenin, primary pharmaceutical reference standard
    Apigenine Apigenol BBL010499
    BCP28288 BDBM7458 BIDD:ER0135
    BIK9018 BPBio1_000406 BRD-K01493881-001-10-4
    BRD-K01493881-001-17-9 BRN 0262620 BS0030
    BSPBio_000368 BSPBio_003384 Bio1_000376
    Bio1_000865 Bio1_001354 Biochem Biophys Res Comm 212: 767 (1997)
    BiomolKI2_000082 BiomolKI_000078 C-16977
    C.I. Natural Yellow 1 C01477 CAS-520-36-5
    CC-24158 CCG-40061 CCRIS 3789
    CHEBI:18388 CHEMBL28 CS-5432
    Chamomile Chamomile Powder D50A2D8A-6D8B-4708-B21E-2DE9580D033F
    DB07352 DSSTox_CID_2391 DSSTox_GSID_22391
    DSSTox_RID_76568 DTXSID6022391 DivK1c_000798
    EBD2138579 EINECS 208-292-3 EU-0100065
    FLAVONE, 4',5,7-TRIHYDROXY- FT-0622445 FT-0623582
    GP1532 GTPL4136 HMS1569C10
    HMS1922P22 HMS2096C10 HMS2230D17
    HMS3260M11 HMS3267D21 HMS3373B18
    HMS3412A08 HMS3561P09 HMS3655D18
    HMS3676A08 HMS502H20 HSCI1_000221
    HSDB 7573 HY-N1201 IDI1_000798
    J10341 K00045 KBio1_000798
    KBio3_002887 KBioGR_002565 KZNIFHPLKGYRTM-UHFFFAOYSA-N
    LMPK12110005 LP00065 LS-2209
    LY 080400 Lopac-A-3145 Lopac0_000065
    M-6923 MCULE-6141069907 MEGxp0_000176
    MFCD00006831 MLS000697626 MLS000859991
    MLS001074874 MLS006011839 N1828
    NCGC00015049-01 NCGC00015049-02 NCGC00015049-03
    NCGC00015049-04 NCGC00015049-05 NCGC00015049-06
    NCGC00015049-07 NCGC00015049-08 NCGC00015049-09
    NCGC00015049-10 NCGC00015049-11 NCGC00015049-12
    NCGC00015049-13 NCGC00015049-14 NCGC00015049-15
    NCGC00015049-16 NCGC00015049-18 NCGC00025057-01
    NCGC00025057-02 NCGC00025057-03 NCGC00025057-04
    NCGC00025057-05 NCGC00025057-06 NCGC00025057-07
    NCGC00025057-08 NCGC00025057-09 NCGC00169835-01
    NCGC00169835-02 NCGC00169835-03 NCGC00256419-01
    NCGC00259092-01 NCGC00260750-01 NCI60_041830
    ND-9076 NINDS_000798 NSC 83244
    NSC-83244 NSC83244 Naringenin, 18
    OR7265T Oprea1_622293 Pelargidenon 1449
    Prestwick0_000414 Prestwick1_000414 Prestwick2_000414
    Prestwick3_000414 Prestwick_719 PubChem9831
    Q-100586 Q-200822 Q424567
    SBB066087 SC-05011 SCHEMBL19428
    SCHEMBL222227 SDCCGMLS-0066379.P001 SMP2_000338
    SMR000326850 SPBio_000416 SPBio_002307
    SPECTRUM200846 SR-01000075663 SR-01000075663-1
    SR-01000075663-3 SR-01000075663-7 SR-01000075663-8
    ST056301 ST2411642 STK801630
    SW196866-2 SY005957 Spectrum2_000428
    Spectrum3_001882 Spectrum4_001999 Spigenin
    TC-307820 TR-018510 TRA0067512
    TS-00897 Tocris-1227 Tox21_201542
    Tox21_302884 Tox21_500065 UCCF 031
    UNII-7V515PI7F6 Versulin ZINC3871576
    ZX-AFC000435 ZX-AT019281 apigenin
    cid_5280443 ghl.PD_Mitscher_leg0.1194 s2262

    DrugBank Name apigenin
    DrugBank DB07352
    CAS Number 100367-40-6, 105-46-4, 36052-37-6, 520-36-5, 8002-66-2
    PubChem Compound 5280443
    KEGG Compound ID C01477
    ChEBI 18388